Exane Derivatives’s Loxo Oncology, Inc LOXO Stock Holding History

Exane Derivatives’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-310	Closed	-$43.4K	–	728
2018 Q4	$43.4K	Buy	+310	New	+$47.1K	0.01%	368

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Exane Derivatives's LOXO Position: Q1 2019 in Review

Exane Derivatives sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 310 shares — an estimated $43.4K sold.

Exane Derivatives first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $43.4K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Exane Derivatives reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Exane Derivatives sold 310 Loxo Oncology, Inc shares in Q1 2019, an estimated $43.4K.
Exane Derivatives first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
Exane Derivatives's Loxo Oncology, Inc position peaked at $43.4K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.